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Abstract 
Background: Epithelioid hemangioendothelioma (EHE) is a rare vascular tumor with 
malignant biological behavior. It arises from endothelial cells, usually within soft tissues, and 
can occur in almost all locations.  
Case Report: We report a unique case of a 25-year-old man who presented with sudden 
attacks of severe back pain followed by acute non-traumatic paraplegia. Emergency 
diagnostics revealed a pathologic fracture of the T7 vertebra with tumor tissue invasion of 
the spinal canal. Furthermore, multifocal metastases were found.  
Results: To achieve en bloc resection, interdisciplinary surgical approaches were indicated. 
Despite multimodal therapy concepts, including radiotherapy and chemotherapy as well as 
endovascular embolization, the patient died within 8 weeks.  
Conclusion: Prognosis of EHE is unpredictable and mainly determined by its location. The 
lesions are potentially aggressive; therefore, en bloc resection should be attempted 
whenever possible. However, as shown in the literature, only 15% of patients are suitable for 
total resection. 
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Introduction 
Epithelioid hemangioendothelioma (EHE) is composed of tumor cells which show 
endothelial differentiation. It is a rare well-differentiated endothelial tumor with 
variable presentation and behavior which may develop at different sites, such as in soft 
tissue, lung, pleura, spleen, heart, liver, as well as intracranial. Primary bone EHE 
accounts for less than 1% of malignant bone tumors; cases occurring in the spine 
region are especially rare. Here, we report a unique case of spinal EHE and present 
surgical treatments, pathologic findings, and imaging characteristics in a 
comprehensive review of the literature. 
Case Report 
A 25-year-old white male was admitted to our hospital with sudden attacks of severe back pain 
followed by acute non-traumatic paraplegia. A high-resolution CT scan and MRI of the thoracic spine 
revealed a pathologic fracture of the T7 vertebral body (VB) with tumor tissue invasion of the spinal 
canal and a space-occupying epidural hematoma between the T5 and T9 VB (fig. 1). The CT scan of 
the thorax region also demonstrated numerous pulmonary foci and pleural affections on both sides. 
Furthermore, lymphonodular and cutaneous metastases were noted. 
We conducted emergency surgery and removed the intraspinal tumor masses as well as the space-
occupying epidural hematoma by extended laminectomy of the T7 VB. The main bulk of the tumor 
was infiltrating the VB and the paravertebral tissue; it was purple and vascular with a soft 
consistency. The stabilization of the posterior column was implemented by dorsal instrumentation 
with internal fixation between the T6 and T8 VB. 
Postoperatively, the patient reported considerable clinical improvements; nevertheless, a high-
grade bilateral, mainly right-sided, leg paresis as well as urinary bladder dysfunction emerged after 
12 h. Early postoperative MRI of the thoracic spine revealed a new space-occupying epidural 
hematoma between the T5 and T6 VB, so that a right-sided hemilaminectomy of the T5 VB was 
urgently indicated to achieve a relief of the myelon. After this operation, significant improvements in 
the form of restored urinary bladder function and a partial restoration of sensory and motor 
deterioration were achieved. However, after a few days there was once again more unfavorable 
progress with progressive bilateral leg paresis, so that further operations were conducted to achieve 
decompression of the spinal canal. 
Due to a recurrent secondary hemorrhage, a total spinal tumor resection via transthoracic T7 
vertebrectomy with VB replacement by cage interposition was performed. The extirpation of some 
pleural foci and pulmonary lesions in the left lower lobe was conducted during the same operation via 
thoracic surgical intervention (fig. 2). After this procedure, clinical improvements were achieved, but 
a considerable amount of blood was lost through the continuous pleural drainage. Due to new 
deterioration of the clinical status, a transthoracic and dorsal reoperation was done in order to seal 
the pleural cavity. 
A histological examination, including immunohistochemical profile, confirmed the endothelial and 
vascular nature of the lesion with both the intervening as well as vascular space-lining cells showing 
positivity for the endothelial cell markers CD31, MIB-1, and factor VIII-related antigen. The diagnosis 
of infiltrating epithelioid hemangioendothelioma was made. The histological profile of the pulmonary 
and pleural lesions was identical to that of the VB (fig. 3). 
Afterwards, a stable neurological status was achieved; however, the origin of the hemorrhage was 
indiscernible and a considerable amount of blood was still being lost through the pleural drainage. All 
coagulation parameters were within normal range over the entire treatment period, and multiple 
blood transfusions were used to temporarily compensate for the lack of blood cells. 
The ensuing limited-field radiotherapy (RT) and chemotherapy with doxorubicin as well as 
endovascular embolization of tumor-supplying intercostal arteries could not stop the recurrent  
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secondary hemorrhage. Despite interdisciplinary surgical management and multimodal therapy 
concepts, the patient died within 8 weeks due to uncontrolled intrathoracic bleeding. 
Discussion 
EHE has had several varying labels such as histiocytoid hemangioma, cellular 
hemangioma, low-grade anaplastic angiosarcoma, and angioendothelioma. The term 
EHE was designed to describe tumors that had an appearance between infantile 
hemangiomas and sarcomas. The highest incidence of the disease occurs during the 
second and third decades. Males and females are affected approximately equally. 
Cytogenetic research has shown inconsistent results, including the translocations 
t(1;3)(p36.3;q25) and t(10;14)(p13;q42), and gains and deletions involving 
chromosomes 11 and 12 [1]. 
EHE typically presents with non-specific signs and symptoms, most commonly 
painful lesions which may be associated with a mass, thereby resulting in a loss of 
function. Vascular or neurological symptoms appear depending on the location. The 
typical radiographic and CT appearance of EHE arising in bone is a lytic lesion without 
matrix mineralization; osseous expansile remodeling may be seen. Joint invasion is a 
common feature and homogeneous enhancement is present on contrast material-
enhanced CT or MRI. The signal intensity characteristics on MR images are non-specific. 
There is low-to-intermediate signal intensity on T1-weighted images and high signal 
intensity on T2-weighted images. The aggressive radiographic appearance of EHE raises 
the suspicion of malignancy. Differential considerations for this radiographic 
presentation include Langerhans’ cell histiocytosis, giant cell tumors, fibrous dysplasia, 
lymphoma, and metastatic diseases [2]. 
Histopathological evaluation is central to the diagnosis of this tumor. At pathological 
analysis, the tumor may be well circumscribed or have indistinct borders. The surface 
is macroscopically light red or purple, with a soft consistency associated with bone 
fragments. The distinct well-lined anastomosing vascular channels often seen in 
hemangiopericytoma are absent in this tumor. Cells may be round or fusiform with a 
central nucleus and prominent intracytoplasmic vacuolation. The positivity of 
endothelial cell markers CD31 and factor VIII-related antigen is essential in the 
diagnosis, as in the specimen in our case. Classification of malignant potential relies on 
the degree of vasoformative activity, atypia of the endothelial cells, and the frequency 
of mitotic activity as predictive signs. Unlike other aggressive vascular tumors, such as 
hemangioendothelial sarcoma or angiosarcoma, the histological grading system is not 
useful for predicting prognosis [1–3]. 
Treatment options and prognosis of spinal EHE are sources of controversy, not least 
because of the small number of patients and the short follow-up periods. We present 
the clinical course and treatment of spinal EHE as documented in the few cases in the 
literature (table 1). 
The 19 cases of EHE were located in the spine region: 5 of them in the cervical, 8 in 
the thoracic and 3 in the lumbar spine region, 1 in the cervical and thoracic spine 
regions, 1 in the thoracic and lumbar spine regions and 1 in all three regions. Eighteen  
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lesions involved the VB and only 1 lesion was intradural with intramedullary extension 
without bone infiltration. 
The main symptom was local pain in 15 cases; pathological fractures were observed 
in 5 patients and perioperative embolization was attempted in 2 cases. Of the 19 cases, 
17 patients underwent surgical intervention. In 3 of those cases, an in sano resection 
was possible and no RT or chemotherapy was needed. The follow-up periods were 
between 8 months and 4 years, and the patients were clinically asymptomatic without 
signs of recurrent or metastatic disease. Fourteen patients underwent subtotal 
resection: 6 cases with adjuvant RT alone, 1 case with adjuvant chemotherapy alone, 2 
cases with combined adjuvant RT and chemotherapy, 1 case with combined adjuvant 
steroid therapy and RT, and 4 cases without any adjuvant therapy. 
There was no tumor recurrence in 3 cases after subtotal resection and adjuvant RT 
within follow-up periods between 6 months and 4 years; there was also no tumor 
recurrence in the 2 cases of subtotal tumor resection and combined adjuvant RT and 
chemotherapy within follow-up periods between 6 months and 11 years. 
In one case, during a follow-up period of 20 months, the patient remained 
neurologically asymptomatic, but abdominal wall metastases appeared despite subtotal 
tumor resection and adjuvant RT. The patient who underwent subtotal tumor resection 
and combined adjuvant steroid therapy and RT was clinically asymptomatic in a follow-
up period of 1 month. In 2 cases, no surgical treatment was attempted; in 1 of these 2 
cases, combined RT and chemotherapy were given and the patient was neurologically 
asymptomatic during a follow-up period of 20 months. In the other case, no further 
therapy was mentioned and the case outcome was not stated. 
Death occurred in 5 cases in total: 3 patients, including our presently reported case, 
died during the treatment course; the other 2 patients died due to liver and lung 
metastases after 20 months in 1 case, and 5 years in the other. In all 5 of these cases, an 
in sano resection was not possible. 
Conclusion 
EHE involving the spine region is extremely rare. The key to diagnosis is the 
immunohistochemical evidence of endothelial differentiation. In questionable cases, it 
is essential to use multiple vascular markers. The histological features of the tumor are 
of no value in predicting clinical outcome. It has been suggested that EHE of soft tissue 
is better regarded as a fully malignant, rather than borderline, vascular neoplasm; 
albeit the prognosis is better than in conventional angiosarcoma. Furthermore, it is 
important to survey not only the skeleton but also the visceral organs to determine the 
full extent of the disease in these patients. In our case, the poor prognosis was 
associated with recurrent secondary hemorrhages and uncontrolled intrathoracic 
bleeding. 
Because of the relatively minor number of reported cases and the short follow-up 
periods, the ideal treatment of these tumors is not entirely clear. Nevertheless, our 
experience through this case and the observations of others suggest that en bloc 
resection is the treatment of choice for spinal EHE; it significantly lengthens the time  
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until local recurrence and is to be attempted whenever possible. However, as shown in 
the literature, in series of primary and metastatic spinal EHE, only 15% of patients are 
suitable for total resection. 
The authors of recent publications suggest radiation as an adjuvant treatment in 
cases of residual tumor. Although chemotherapy and immunotherapy have been used 
as adjuvant treatments, their role has not been clearly defined. 
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Table 1. Clinical details of documented cases of spinal EHE 
                     
                     
Year of publication, 
authors 
  Age years, 
gender 
  Presenting 
symptoms 
  Localization    Management    Follow-up period, 
outcome 
                     
                     
2011,  
our present case 
  25, M    back pain, acute 
paraplegia 
  T7 VB; pulmonary, 
pleural, lymphonodular 
and cutaneous 
metastases 
  T7 vertebrectomy decompression, 
stabilization, resection of pulmonary 
metastases, embolization, RT and 
chemotherapy 
  died within 8 weeks 
due to uncontrolled 
intrathoracic 
bleeding 
2010,  
Neves et al. [14] 
  51, F    lower back pain, 
progressive 
paraplegia 
  L1 VB    L1 corpectomy, vertebral spacer, 
lateral plate fixation, T10–L4 pedicle 
instrumentation and fusion 
  6 years, 
asymptomatic 
2006, 
Gokhan et al. [12] 
  30, M    lower back pain, 
urinary incontinence, 
numbness, difficulty 
in walking 
  L1 and L2 VB    L1 vertebrectomy, total tumor 
resection, T12–L2 interbody fusion, 
T12–L3 stabilization 
  8 months,  
no major complaint  
2005,  
Abuzallouf et al. [3] 
  41, M    lower back pain, 
urinary retention, 
numbness 
  spinal intradural tumor 
at the level of T12 
  tumor resection, RT    4 years,  
no tumor recurrence 
2005,  
Adler et al. [2] 
  16, M     syncopal episodes 
and cephalgia 
  cervical spine, skull 
base, skeleton, lungs, 
liver, kidneys 
  subtotal excisions    died during the 
treatment course 
2005,  
Aquilina et al. [5] 
  17, M    lower back pain    T10 VB    T10 vertebrectomy, iliac crest strut 
graft, stainless steel plate, extensive 
resection of the tumor, RT and 
chemotherapy 
  11 years, 
asymptomatic 
2005,  
Aquilina et al. [5] 
  60, M    neck pain, 
progressive flexion 
deformity 
  C2, C3, and C4 VB    posterior occipitocervical 
stabilization, RT 
  died after 20 months 
of hepatic metastases 
2004,  
Casey et al. [8] 
  60, M    neck pain, fixed neck 
flexion  
  C2, C3 and C4 VB    posterior occipitocervical 
stabilization, RT 
  2 years, 
asymptomatic 
2003,  
Evans et al. [1] 
  25, M    lower back pain    T11 VB, skull and left 
femur 
  stabilization and chemotherapy    5 years,  
died due to liver and 
lung metastases 
2001,  
Brennan et al. [7] 
  28, M    numbness of both 
legs, weakness, 
unbalanced gait 
  C5, C6 VB and C7 
vertebral transverse 
process 
  embolization, fusion and 
decompression, RT 
  6 months,  
decreased 
complaints 
2001,  
Faust et al. [11] 
  58, F    segmental sensory 
disturbance, 
Horner’s syndrome 
  C7–T4 VB    subtotal tumor excision    died within 4 weeks 
2001,  
Chau et al. [9] 
  17, F     left-sided weakness, 
cephalgia 
  lateral mass of C1 
vertebra, left occipital 
condyle 
  suboccipital craniectomy    case outcome not 
stated 
1996,  
Boutin et al. [6] 
  24, M    neck stiffness and 
back pain 
  multiple lesions 
(cervical, thoracic and 
lumbar), 45 bones 
  chemoradiotherapy    20 months, 
neurologically 
asymptomatic 
1996,  
Ellis et al. [10] 
  31, F    lower back pain    L2 VB    L2 vertebrectomy, strut grafting, 
excision of the L1–L2 and L2–L3 
intervertebral discs 
  18 months, 
neurologically 
asymptomatic 
1992,  
Abrahams et al. [4] 
  34, M    back pain and leg 
numbness 
  T3 VB    biopsy; further therapy was not 
mentioned 
  case outcome not 
stated 
1986,  
Tsuneyoshi et al. [15] 
  73, M    pain    T10, T12, and L1 
vertebrae 
  curettage and RT    case outcome not 
stated 
1986,  
Tsuneyoshi et al. [15] 
  16, M    pain    T9 VB    curettage    4 years, 
asymptomatic 
1986,  
Tsuneyoshi et al. [15] 
  26, M    pain    T11 VB    tumor resection and RT    20 months, 
asymptomatic, 
abdominal wall 
metastases 
1985,  
Maruyama et al. [13] 
  43, F    pain and cord 
compression 
  T3 VB and multicentric 
bone involvement 
outside the spine 
  tumor resection, steroid therapy 
and RT 
  1 month, 
asymptomatic 
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Fig. 1. T1-weighted axial MR image after contrast administration (left) and sagittal STIR MR image 
(right) showing the lesion. 
 
 
 
Fig. 2. CT scan after extirpation of pleural foci and pulmonary lesions in the left lower lobe. 
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Fig. 3. Pleomorphic neoplastic cells are seen in the center of the picture (Hematoxylin and Eosin 
stain, original magnification × 200). 
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